Subject(s)
Carcinoma, Transitional Cell/diagnostic imaging , Creatine Kinase/analysis , Urinary Bladder Neoplasms/diagnostic imaging , Aged , Biomarkers/blood , Carcinoma, Transitional Cell/blood , Carcinoma, Transitional Cell/surgery , Creatine Kinase/blood , Cystoscopy , Female , Humans , Ultrasonography , Urinary Bladder Neoplasms/blood , Urinary Bladder Neoplasms/surgerySubject(s)
Lung Diseases/diagnosis , Sjogren's Syndrome/physiopathology , Female , Humans , Male , Middle Aged , Retrospective StudiesABSTRACT
Osteoporosis is a common systemic disease leading to premature fractures. This article reviews the state of the art of assessing the risk of future osteoporotic fracture and summarizes the prevention and treatment of the condition.
Subject(s)
Osteoporosis/therapy , Adrenal Cortex Hormones/adverse effects , Bone Density , Diphosphonates/therapeutic use , Exercise , Female , Fractures, Spontaneous/etiology , Hormone Replacement Therapy , Humans , Osteoporosis/physiopathology , Risk FactorsABSTRACT
Signed into law last August, the Balanced Budget Act of 1997 includes significant changes in the Medicare program that will affect beneficiaries, health care providers, and state governments. Many of the changes regarding Medicare are effective January 1, 1998 and participating physicians should be aware of some surprising pitfalls and opportunities contained in the new law.
Subject(s)
Budgets/legislation & jurisprudence , Medicare/economics , Cost Control , Humans , Licensure , Medicare/standards , Preferred Provider Organizations/legislation & jurisprudence , Preferred Provider Organizations/organization & administration , Tennessee , United StatesSubject(s)
Deductibles and Coinsurance/legislation & jurisprudence , Fraud/legislation & jurisprudence , Medicaid/legislation & jurisprudence , Medicare/legislation & jurisprudence , Patient Credit and Collection/legislation & jurisprudence , Deductibles and Coinsurance/economics , Fees, Medical/legislation & jurisprudence , Humans , Insurance Claim Review/legislation & jurisprudence , Medicaid/economics , Medicare/economics , Patient Credit and Collection/economics , United StatesABSTRACT
Clearly osteoporosis is a major scourge of Western society but interest in the condition has risen exponentially in the last 10 years partly because of advances in our understanding of the disease process, the ability to predict its onset, to reverse the process of bone loss and to measure the consequences of treatment, but also in part due to increased public awareness. Further advances are likely, especially in our understanding of the genetic background of the disorder and our ability, not only to reduce bone resorption, but also to enhance bone formation. The challenge will be how to target our improved therapies at the expanding elderly population to reduce the impact and costs of fracture.
